A major discovery in cancer research is emerging with the use of nanobodies to reactivate mutated p53. This essential cancer inhibitor protein is frequently disabled in several forms of cancer, causing uncontrolled https://bookmarking1.com/story21988250/mini-antibodies-revive-the-p53-protein-new-potential-pathway-for-cancer-therapy